global avian flu treatment market, avian flu treatment market overview, avian flu treatment market size, avian flu treatment market report, avian flu treatment market share, avian flu treatments market
What is the current size and annual growth rate of the avian flu treatment market?
The avian flu treatment market size has grown strongly in recent years. It will grow from $12.59 billion in 2024 to $13.81 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increased demand for avian flu treatment, rise in measures to prevent the spread of bird flu, increased availability of treatment options, increased investment for healthcare infrastructure, and increased demand for poultry for consumption.
The avian flu treatment market size is expected to see strong growth in the next few years. It will grow to $19.69 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to growing awareness and diagnosis, government initiatives for pandemic preparedness, rising research and development investments, the need for effective therapeutics against avian influenza, and extensive research and development efforts. Major trends in the forecast period include the development of novel therapeutic approaches, future innovation and technologies, collaborative research efforts, new business development, and investment opportunities, and telemedicine and remote consultation implementation.
Get Your Free Sample of The Global Avian Flu Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16352&type=smp
Which major factors have contributed to the expansion of the avian flu treatment market?
The growing awareness and diagnosis are expected to drive the growth of the avian flu treatment market going forward. Awareness is the recognition of a condition, while diagnosis is the identification of a specific issue based on that awareness. The demand for avian flu treatment arises from the urgent need to safeguard public health, prevent potential pandemics, and protect poultry populations from significant economic losses. Awareness and early diagnosis are crucial for effective avian flu treatment, enabling prompt intervention and containment to prevent spread. For instance, in April 2024, as per the World Health Organization (WHO), a Switzerland-based intergovernmental organization, more than 8000 people were under active surveillance in the US from February 9, 2022, to March 29, 2024, after being exposed to animals thought to be HPAI A (H5N1) virus-infected. Therefore, growing awareness and diagnosis are driving growth in the avian flu treatment market.
How is the avian flu treatment market segmented?
The avian flu treatment market covered in this report is segmented –
1) By Type: Antibiotics, Vaccines, Antiviral Agents, Immunoglobulins
2) By Distribution Channel: Online Pharmacies, Offline Pharmacies
3) By End User: Hospital, Institutional Health Centers, Clinics
Subsegments:
1) By Antibiotics: Broad-Spectrum Antibiotics, Tetracycline Antibiotics, Penicillin-Based Antibiotics, Macrolide Antibiotics, Cephalosporins, Antimicrobial Peptides
2) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Subunit Vaccines, Dna Vaccines, Bivalent And Multivalent Vaccines
3) By Antiviral Agents: Neuraminidase Inhibitors (Oseltamivir, Zanamivir), M2 Ion Channel Inhibitors (Amantadine), Polymerase Inhibitors, Protease Inhibitors, Antiviral Combination Therapies
4) By Immunoglobulins: Human Immunoglobulin (Ivig), Monoclonal Antibodies, Hyperimmune Serum, Polyvalent Immunoglobulins, Avian Flu-Specific Immunoglobulins
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/avian-flu-treatment-global-market-report
Who are the top competitors in the avian flu treatment market?
Major companies operating in the avian flu treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Gilead Sciences Inc., Baxter International Inc., CSL Limited, Moderna Inc., Cipla Ltd., Shionogi & Co. Ltd., Novavax Inc., Seqirus Pty Ltd., Sinovac Biotech Ltd., Emergent BioSolutions Inc., Dynavax Technologies Corporation, CureVac AG, Valneva SE, BioCryst Pharmaceuticals Inc., Siga Technologies Inc., Aridis Pharmaceuticals Inc., Inovio Pharmaceuticals Inc., Biolyse Pharma
Which key trends are expected to influence the avian flu treatment market in the coming years?
Major companies in the avian flu treatment market are focusing on creating partnerships to enhance efficacy and speed up the development of new treatments. Partnerships involve collaborations between pharmaceutical companies, research institutions, and government agencies to pool resources, share expertise, and conduct innovative clinical trials. For instance, in April 2024, CureVac N.V., a Germany-based biotechnology company, partnered with GSK plc, a UK-based pharmaceutical company, to create an investigative influenza A (H5N1) pre-pandemic vaccine candidate to address the potential future pandemic threat posed by the H5N1 avian influenza virus. This collaboration aims to evaluate the safety, reactogenicity, and immunogenicity of the monovalent vaccine candidate, which encodes an influenza A H5-antigen using CureVac’s proprietary second-generation mRNA backbone. The combined Phase 1/2 study will assess the vaccine candidate’s safety and effectiveness in healthy adults aged 18 to 64 as well as in older adults aged 65 to 85.
Which regional trends are influencing the avian flu treatment market, and which area dominates the industry?
North America was the largest region in the avian flu treatment market in 2023. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the avian flu treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Avian Flu Treatment Market Report 2025 Offer?
The avian flu treatment market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Avian flu treatment refers to the medical interventions and strategies aimed at managing and alleviating the symptoms of avian influenza, commonly known as bird flu, in infected individuals. Avian influenza is caused by viruses that primarily infect birds, but certain strains, such as H5N1 and H7N9, have been known to infect humans and cause severe illness or even death in some cases.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16352
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
